Sana Biotechnology, Inc.
SANA
$3.20
-$0.06-1.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 19.75% | -39.55% | 55.06% | -89.92% | -0.65% |
| Total Depreciation and Amortization | -21.68% | -4.32% | 11.69% | -21.70% | -4.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -29.26% | 123.17% | -85.57% | 670.80% | 228.81% |
| Change in Net Operating Assets | -290.63% | 389.81% | 120.70% | 68.99% | -354.23% |
| Cash from Operations | -14.52% | -10.91% | 11.09% | 31.97% | -3.17% |
| Capital Expenditure | 67.01% | -2,029.27% | -136.61% | 182.35% | 68.81% |
| Sale of Property, Plant, and Equipment | -62.48% | 386.03% | -64.40% | 50.99% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 403.84% | 66.16% | -769.64% | -56.41% | -65.31% |
| Cash from Investing | 399.69% | 65.65% | -725.33% | -53.74% | -64.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.25% | -2.30% | -1.16% | -1.18% | -- |
| Issuance of Common Stock | -99.67% | -83.82% | 18,575.81% | -47.91% | 61.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 200.00% | -- |
| Cash from Financing | -100.73% | -83.89% | 19,425.85% | -42.87% | 52.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 137.89% | -198.13% | 229.07% | 19.99% | -5,551.23% |